NCT00559884View on ClinicalTrials.gov

A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2007

Conditions
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
Interventions
DRUG

GSK189075 (Modified and immediate release formulations)

Trial Locations (1)

43212

GSK Investigational Site, Columbus

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY